Considering that CD13, known to be expressed by the tumor vasculature, may represent a target receptor for drug delivery to the tumor vasculature [2, 20], the potential use of G4 as a ligand for drug delivery to tumors was also investigated. This evidence concerns the gene ANPEP and neoplasm.